Drugmakers Merck & Co and Eli Lilly & Co are being investigated by the U.S. Attorney’s Office in Pennsylvania and other federal agencies over drug pricing practices, the companies disclosed. Merck, in a regulatory filing late on Thursday, said it had received a civil investigative demand from the attorney’s office over the pricing of its asthma inhaler product, Dulera. Eli Lilly & Co also disclosed in a regulatory filing last week that the Pennsylvania Attorney’s Office and the U.S. Department of Justice were investigating the company’s distribution deals with wholesalers.
Read more here:
U.S. federal agencies investigate Merck, Lilly drug pricing
